Anupam Rasayan Q1 FY27: Revenue up 36%, PAT rises 6%

BSE filing and SEBI Regulation 47 compliance

Anupam Rasayan India Limited submitted its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27) to the Bombay Stock Exchange on August 15, 2026. The filing was made in line with SEBI Regulation 47, which requires listed companies to disclose and publish financial results. The company also confirmed that the results were published in newspapers, including Financial Express and Dhabkar. Alongside print publication, it stated that the full results were available online. The disclosure provides investors with a formal record of the quarter’s standalone and consolidated performance.

What the quarter covers and key dates

The results relate to the April to June 2026 period, which is Q1 of FY27. The company’s board meeting to consider the unaudited financial results was scheduled for August 14, 2026. An earnings call was also scheduled on August 14, 2026 at 2:00 PM IST, with participation from the Managing Director, CEO, CFO, and Deputy CFO. The subsequent BSE filing date cited in the disclosure is August 15, 2026. These dates matter for tracking when numbers became publicly available and when management commentary could be accessed.

Consolidated performance: revenue, profit and margin

On a consolidated basis, the filing reported revenue of INR 6,675 million for Q1 FY27, up 36% year-on-year from INR 4,907 million in Q1 FY26. Consolidated profit after tax (PAT) was reported at INR 512 million, a 6% increase from INR 485 million a year earlier. Consolidated EBITDA rose to INR 1,749 million from INR 1,292 million, implying 35% year-on-year growth. The consolidated EBITDA margin was reported at 26.2%, up from 26.0% in Q1 FY26.

Revenue from operations versus total revenue

Separate disclosures in the provided material also cited consolidated revenue from operations of INR 6,549.80 million for Q1 FY27, up 34.7% from INR 4,858.27 million in the comparable period. In another summary of the same quarter, the quarter’s revenue was referenced as INR 6,549.8 million, while total revenue was referenced as INR 6,675.45 million. The difference indicates that some figures refer to revenue from operations, while others refer to a broader revenue or total income measure. In the same set of disclosures, net profit attributable to owners was stated as INR 386.39 million, compared with INR 340.36 million in the earlier comparable period.

Standalone results: growth and margin expansion

On a standalone basis, revenue was reported at INR 3,349 million (including other income), up 4% from INR 3,205 million in Q1 FY26. Another line item in the data cited standalone revenue from operations of INR 3,288.05 million for Q1 FY27, compared with INR 3,156.94 million year-on-year. Standalone EBITDA rose 17% to INR 1,155 million, while the EBITDA margin expanded to 34% from 31%. Standalone PAT increased 8% to INR 320 million, up from INR 297 million.

Subsidiary and associate updates cited in the quarter

The quarter’s disclosures also highlighted contribution and performance of group entities. Subsidiary Tanfac Industries Limited contributed revenue of INR 1,891.99 million for the quarter. Associate Tangent Science Private Limited reported a net loss after tax of INR 25.25 million for the same period. These figures help investors reconcile consolidated performance with contributions from subsidiaries and the impact of associates.

Earnings per share and reported profitability lines

For Q1 FY27, standalone basic EPS (not annualised) was reported at INR 2.81. Consolidated basic EPS attributable to owners (not annualised) was reported at INR 3.39, with diluted EPS also cited at INR 3.39 in one disclosure. In addition to the consolidated PAT figure of INR 512 million cited in the filing summary, another profitability line stated net profit attributable to owners at INR 386.39 million. Since these are presented as different measures in the provided material, they should be treated as separate reported lines rather than interchangeable values.

Cost line and other datapoints reported

A PTI-based summary in the provided text stated that total income rose 36% to INR 6,675.4 million from INR 4,907.0 million year-on-year. The same summary stated expenses were INR 5,978.6 million versus INR 4,278.8 million in the year-ago period. Another block of “quick details” included a latest-quarter net debt figure of INR 11,000 million and a current market price (CMP) of INR 1,209.4. It also listed a previous quarter revenue of INR 6,310 million, previous quarter PAT of INR 550 million, and previous quarter EBITDA margin of 22%.

Key numbers table (as reported)

Market impact and why the filing matters

The immediate market relevance of the BSE filing is that it formally places the quarter’s unaudited numbers on record and confirms the company’s compliance with disclosure requirements under SEBI Regulation 47. From the financial data presented, the quarter shows year-on-year growth in consolidated revenue and consolidated EBITDA, along with a reported expansion in consolidated EBITDA margin to 26.2%. The standalone set also indicates margin expansion to 34% from 31%, alongside a moderate rise in standalone revenue. The disclosures also point to differences between “total revenue/total income” and “revenue from operations,” and between consolidated PAT and net profit attributable to owners, which investors typically track as distinct reported measures.

Conclusion

Anupam Rasayan’s Q1 FY27 disclosure to the BSE dated August 15, 2026 reported strong year-on-year growth in consolidated revenue, higher EBITDA, and a modest rise in consolidated PAT, along with improved margins. The company also confirmed that the results were published in Financial Express and Dhabkar and made available online. Investors tracking the quarter have multiple reported lines in the provided material, including consolidated revenue of INR 6,675 million and consolidated revenue from operations of INR 6,549.80 million, as well as separate profit measures. The next key reference point mentioned in the material was the scheduled board meeting and earnings call on August 14, 2026, where management was expected to discuss the unaudited results.